Temasek prepares $1b sale of Zuellig Pharma stake
The pharma has a network in Singapore, Philippines, Thailand, and other Asian countries.
According to Bloomberg, Temasek Holdings Pte is exploring a sale of its stake in Asian drug distributor Zuellig Pharma, people familiar with the matter said.
The Singapore state investment firm has been speaking with advisers about a potential sale of its 20 percent stake in Zuellig Pharma, which commands vast pharmaceutical distribution networks in about a dozen Asian markets, according to the people. Temasek may seek around $1 billion for its holding in the Singapore-based company, the people said, asking not to be identified because the discussions are private.
Read the full report here.